Su Q, Nyi TS, Li L · Cochrane Database Syst Rev (2015)
No plain-language summary recorded for this citation — open the paper to read its abstract.
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
643 peer-reviewed studies
What the evidence says
Most Verapamil studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 1975–2026 with a typical study size of 1,434 participants.
Based on 642 studies · 20 meta-analyses · 613 RCTs · 3,545 total participants
Confidence
High confidenceBy outcome
Only 12 studies in the last 5 years · Latest meta-analysis: 2026
Su Q, Nyi TS, Li L · Cochrane Database Syst Rev (2015)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Hansen JF · Drugs (1991)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Hansen JF · Cardiovasc Drugs Ther (1994)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Messerli FH, Hansen JF, Gibson RS, Schechtman KB, Boden WE · J Hypertens (2001)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Wang L, Cheng Z, Gu Y, Peng D · Biomed Res Int (2015)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Sadagopan A · Andrologia (2019)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Dong EW, Connelly JE, Borden SP, Yorzyk W, Passov DG, Kupelnick B · Pharmacotherapy (1997)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Belhassen B, Viskin S · Pacing Clin Electrophysiol (1993)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Tu S, Zhang R, Zheng Q, Wang J, Chen Y, Li X · Cardiovasc Drugs Ther (2026)
No plain-language summary recorded for this citation — open the paper to read its abstract.
· Am J Cardiol (1990)
No plain-language summary recorded for this citation — open the paper to read its abstract.
White WB, Johnson MF, Anders RJ, Elliott WJ, Black HR · Am Heart J (2001)
No plain-language summary recorded for this citation — open the paper to read its abstract.
White WB, Johnson MF, Black HR, Fakouhi TD · Ethn Dis (1999)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Zou Z, Xu FY, Wang L, An MM, Zhang H, Shi XY · J Hum Hypertens (2011)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Pepine CJ, Faich G, Makuch R · Clin Cardiol (1998)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Su Q, Li L, Liu Y · Clin Cardiol (2013)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Andrews TC, Reimold SC, Berlin JA, Antman EM · Circulation (1991)
No plain-language summary recorded for this citation — open the paper to read its abstract.
White WB, Johnson MF, Black HR, Elliott WJ, Sica DA · Am J Hypertens (2001)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Hansen JF · J Cardiovasc Pharmacol (1991)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Delaney B, Loy J, Kelly AM · Eur J Emerg Med (2011)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Persson S · Drugs (1991)
No plain-language summary recorded for this citation — open the paper to read its abstract.